Wednesday, July 15, 2020 Daily Archives

Accelerate Cell and Gene Therapy Development and Manufacturing with Fully Integrated Closed CAR-T Cell Therapy Platform

by

For many years, the primary forms of cancer treatment have been chemotherapy, radiation, and surgery. An amazing breakthrough known as chimeric antigen receptor (CAR) T-cell therapy is being studied in the treatment of various types of cancer, including acute and chronic lymphoblastic leukemia, non-Hodgkin lymphoma, myeloma, and solid tumors. Developing innovative advanced therapies is one of our greatest opportunities to dramatically improve patients’ lives. WuXi Advanced Therapies recently announced the expansion of its service capabilities by offering a fully integrated…

July 15, 2020

Blockchain ideal for coronavirus vaccine distribution, says expert

by

Blockchain tech is ideal for SARS-CoV-2 vaccine supply chains according to an expert who says efficiency and trust are vital. In the six or so months since SARS-CoV2 – the causative agent of COVID-19 – was detected, public health efforts have focused on finding ways to slow the spread of the virus until a vaccine could be developed. In parallel vaccine developers have accelerated their efforts. According to the World Health Organisation (WHO) there are 23 candidate SARS-CoV2 jabs in…

July 15, 2020

Amgen invests further $421m in China’s Beigene

by

Amgen has upped its investment in drugmaker Beigene to further access the increasingly large pharmaceutical market, China. Last year, Thousand Oaks, California-based Amgen closed a strategic collaboration with BeiGene, investing $2.8 billion to gain a presence in what’s becoming an ever-more essential market for global drug development. The investment earned it an R&D pact and ownership of about one-fifth of the Chinese oncology drug company. Now the firm has snapped up a chunk of additional shares in a move to maintain its…

July 15, 2020